Finn Patrick John's Form 4 filing
Twist Bioscience Corp (TWST) · filed Feb 17, 2026
- Accession no.
- 0001214659-26-002041
- Filed
- Feb 17, 2026
- Trade date
- Feb 12-13, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $263.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Finn Patrick JohnCIK 0001755970 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Common Stock | MOption exerciseAcquired | +1,000 | $23.33 | +$23,330 | 308,788 | Direct | |
| Feb 12, 2026 | Common Stock | MOption exerciseAcquired | +1,500 | $26.66 | +$39,990 | 310,288 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −3,500 | $50.23 | −$175,805 | 306,788 | Direct | |
| Feb 13, 2026 | Common Stock | MOption exerciseAcquired | +500 | $23.33 | +$11,665 | 307,288 | Direct | |
| Feb 13, 2026 | Common Stock | MOption exerciseAcquired | +712 | $26.66 | +$18,981.92 | 308,000 | Direct | |
| Feb 13, 2026 | Common Stock | SSaleDisposed | −1,750 | $50.04 | −$87,570 | 306,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 33,012 | Direct | |
| Feb 12, 2026 | Common Stock | MOption exerciseDisposed | −1,000 | $0.00 | $0 | 18,705 | Direct | |
| Feb 13, 2026 | Common Stock | MOption exerciseDisposed | −712 | $0.00 | $0 | 32,300 | Direct | |
| Feb 13, 2026 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 18,052 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.